Home › NDC Lookup › RxCUI directory › RxCUI 1010603

Buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] — RxCUI 1010603

Name: Buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] (RxCUI 1010603)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1010603 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1010603

Official nameBuprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asSuboxone 2/0.5 Sublingual Film; Suboxone 2 MG / 0.5 MG Sublingual Film; Suboxone 2/0.5 (buprenorphine HCl / naloxone HCl dihydrate) Sublingual Film

FDA products mapped4

Package NDCs mapped4

Reported Medicaid activity (SDUD)2,330,183 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Naloxone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Naloxone works by knocking opioids off their receptors in the brain — the spots opioids attach to in order to cause their effects. When those receptors are blocked by naloxone, bre...
What exactly does naloxone injection do in an overdose?
Call 911 immediately — that's not optional. Naloxone wears off faster than most opioids, so even if the person wakes up and seems okay, they can slip back into overdose once the na...
What do I do after I give someone a dose of naloxone injection?

📖 Read our full Naloxone Injection guide →

🕸️ Concept Web — How Buprenorphine 2 MG / naloxone 0.5 MG Sublingual... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [Suboxone] RxCUI 1010603 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Buprenorphine 1819 IN
- Naloxone 7242 IN
- Buprenorphine / naloxone 352364 MIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Suboxone 352990 BN
Dose forms 12

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Buprenorphine / naloxone Sublingual Film 2269593 SCDF
- Buprenorphine / naloxone Oral Film Product 2269592 SCDG
- Buprenorphine / naloxone Oral Product 1151359 SCDG
- Buprenorphine / naloxone Sublingual Product 1294831 SCDG
- Buprenorphine / naloxone Sublingual Film [Suboxone] 2269595 SBDF
- Suboxone Oral Film Product 2269596 SBDG
- Suboxone Oral Product 1180238 SBDG
- Suboxone Sublingual Product 1297024 SBDG
- +4 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film 1010600 SCD
- Buprenorphine 2 MG 353390 SCDC
- Naloxone 0.5 MG 343216 SCDC
- Buprenorphine 2 MG / naloxone 0.5 MG [Suboxone] 1010601 SBDC

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film SCD · 1010600
Buprenorphine 2 MG SCDC · 353390
Naloxone 0.5 MG SCDC · 343216
Buprenorphine / naloxone Sublingual Film SCDF · 2269593
Buprenorphine / naloxone Oral Film Product SCDG · 2269592
Buprenorphine / naloxone Oral Product SCDG · 1151359
Buprenorphine / naloxone Sublingual Product SCDG · 1294831

Brand-Name Concepts

Buprenorphine 2 MG / naloxone 0.5 MG [Suboxone] SBDC · 1010601
Buprenorphine / naloxone Sublingual Film [Suboxone] SBDF · 2269595
Suboxone Oral Film Product SBDG · 2269596
Suboxone Oral Product SBDG · 1180238
Suboxone Sublingual Product SBDG · 1297024
Suboxone BN · 352990

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 1010603 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
12496-1202-03	30 POUCH in 1 CARTON (12496-1202-3) / 1 FILM, SOLUBLE in 1...	Suboxone	INDIVIOR INC.	2010-09-13
12496-1204-03	30 POUCH in 1 CARTON (12496-1204-3) / 1 FILM, SOLUBLE in 1...	Suboxone	INDIVIOR INC.	2012-08-24
12496-1208-03	30 POUCH in 1 CARTON (12496-1208-3) / 1 FILM, SOLUBLE in 1...	Suboxone	INDIVIOR INC.	2010-09-13
12496-1212-03	30 POUCH in 1 CARTON (12496-1212-3) / 1 FILM, SOLUBLE in 1...	Suboxone	INDIVIOR INC.	2012-08-24

Observed labelers: INDIVIOR INC. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.